2012 Clinical Trials Conditions 
The Cannigma
MARCH 7, 2022
CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. What can the current clinical trials tell us?
Greencamp
FEBRUARY 17, 2019
Usually, the diagnosis involves excluding conditions like parasitic infections, lactose intolerance tests and small intestinal bacterial overgrowth which all produce symptoms like IBS. Constant gut symptoms often lead to the development of other conditions like anxiety , depression , migraines , sleeping problems and fatigue.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
OCTOBER 13, 2020
Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .
CannaMD
AUGUST 26, 2020
Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., Conditioned place preference. mice/rats). The studies were then broken into eight categories: Cocaine self-administration. Brain-stimulation reward. Hepatic protection.
SpeedWeed
JULY 31, 2021
In Colorado , cannabis arrests plummeted 68% from 2012 to 2019. In states that have already reformed cannabis prohibition, incarceration rates, especially for non-violent criminals, such as those who possess cannabis, have decreased dramatically.
Cannabis Law Report
JANUARY 19, 2022
Congressman Moran introduced the AUTISM Educators Act in 2012, which funded partnerships between public schools and higher education and non-profit organizations to promote teaching skills for educators working with high functioning autism students. The Company also operates an infrastructure business based in India.
The Cannigma
JUNE 15, 2021
The first mention of it we found on the web was a 2012 news article from the Los Angeles Times , telling the story of then-five-year-old Jayden David, a boy who was suffering from Dravet syndrome, a rare form of treatment-resistant epilepsy. Unfortunately there is much less data on these conditions, and the results from the studies are mixed.
Expert insights. Personalized for you.
140 
Let's personalize your content